resveratrol has been researched along with Hyperinsulinism in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campagnole-Santos, MJ; de Paula, AM; dos Santos, RA; Ferreira, AV; Garcia, ZM; Guimarães, AL; Oliveira Andrade, JM; Paraíso, AF; Santos, SH; Sinisterra, RD; Sousa, FB | 1 |
| Chen, W; Fan, S; Jin, X; Wang, L; Xie, X; Xue, N | 1 |
| González-Ortiz, M; Lizárraga-Valdez, R; Martínez-Abundis, E; Méndez-del Villar, M; Pérez-Rubio, KG | 1 |
| Hansen, KD; Hartung, T; Kleensang, A; Myint, L; Zhao, L | 1 |
| Louis, XL; MohanKumar, SK; Netticadan, T; Taylor, CG; Thandapilly, SJ; Yu, L; Zahradka, P | 1 |
| Blagosklonny, MV; Demidenko, ZN; Leontieva, OV; Paszkiewicz, G | 1 |
| Chen, LL; Ding, HC; Shang, J; Sun, H; Xiao, FX; Xiao, H | 1 |
1 trial(s) available for resveratrol and Hyperinsulinism
| Article | Year |
|---|---|
Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion.
Topics: Adiposity; Adult; Area Under Curve; Biomarkers; Blood Glucose; Body Mass Index; Cholesterol, HDL; Double-Blind Method; Female; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Mexico; Middle Aged; Predictive Value of Tests; Resveratrol; Stilbenes; Time Factors; Treatment Outcome; Triglycerides; Weight Loss | 2014 |
6 other study(ies) available for resveratrol and Hyperinsulinism
| Article | Year |
|---|---|
Cross talk between angiotensin-(1-7)/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice.
Topics: Administration, Oral; Angiotensin I; Animals; Antimetabolites; Cells, Cultured; Diet, High-Fat; Drug Evaluation, Preclinical; Gene Expression; Glucose Intolerance; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Lipolysis; Male; Mice; Obesity; Peptide Fragments; Primary Cell Culture; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Resistin; Resveratrol; Sirtuins; Stilbenes | 2014 |
Novel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamster.
Topics: Animals; Bezafibrate; Cricetinae; Diet, High-Fat; Drug Design; Gene Expression Regulation; Hyperinsulinism; Hyperlipidemias; Hypolipidemic Agents; Liver; Male; Muscle, Skeletal; Pentanoic Acids; PPAR alpha; Resveratrol; Sirtuin 1; Stilbenes; Triglycerides | 2014 |
Joint Bounding of Peaks Across Samples Improves Differential Analysis in Mass Spectrometry-Based Metabolomics.
Topics: Adolescent; Androgens; Animals; Arabidopsis; Cell Line; Female; Humans; Hyperinsulinism; Infant; Liver; Mass Spectrometry; MCF-7 Cells; Metabolomics; Mice; Plant Leaves; Resveratrol | 2017 |
Treatment with low-dose resveratrol reverses cardiac impairment in obese prone but not in obese resistant rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biomarkers; Blood Glucose; Diet, High-Fat; Disease Resistance; Disease Susceptibility; Echocardiography; Heart; Heart Diseases; Hyperglycemia; Hyperinsulinism; Male; Obesity; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2012 |
Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet.
Topics: Animals; Cell Line, Tumor; Cellular Senescence; Diet, High-Fat; Humans; Hyperinsulinism; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin; Insulin Resistance; Male; Mice; Obesity; Resveratrol; Sirolimus; Stilbenes; TOR Serine-Threonine Kinases; Transcription, Genetic; Weight Gain | 2013 |
Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase.
Topics: Animals; Antioxidants; Cyclic AMP-Dependent Protein Kinases; Diet; Enzyme Activation; Fatty Liver; Glucose Clamp Technique; Humans; Hyperinsulinism; Liver; Male; Rats; Resveratrol; Stilbenes; Triglycerides | 2008 |